A randomized phase II study of maintenance therapy with multiepitope vaccine tedopi (OSE2101) +/- nivolumab or FOLFIRI after induction chemotherapy (CT) with FOLFIRINOX in patients (Pts) with advanced pancreatic ductal adenocarcinoma (aPDAC) (TEDOPaM - PR

Affiliation auteursAffiliation ok
TitreA randomized phase II study of maintenance therapy with multiepitope vaccine tedopi (OSE2101) +/- nivolumab or FOLFIRI after induction chemotherapy (CT) with FOLFIRINOX in patients (Pts) with advanced pancreatic ductal adenocarcinoma (aPDAC) (TEDOPaM - PR
Type de publicationJournal Article
Year of Publication2019
AuteursNeuzillet C., Hautefeuille V., Lambert A., Garcia-Larnicol M-L., Vernerey D.
JournalANNALS OF ONCOLOGY
Volume30
Date PublishedOCT
Type of ArticleMeeting Abstract
ISSN0923-7534